# This is a Non-interventional, Study to Assess Demographic Characteristics and Patient Reported Outcomes in China Patients With SEA Treated With Benralizumab

> **NCT06862206** · — · RECRUITING · sponsor: **AstraZeneca** · enrollment: 1000 (estimated)

## Conditions studied

- Chronic Obstructive Pulmonary Disease

## Interventions

- **OTHER:** benralizumab

## Key facts

- **NCT ID:** NCT06862206
- **Lead sponsor:** AstraZeneca
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** RECRUITING
- **Start date:** 2025-07-11
- **Primary completion:** 2027-12-31
- **Final completion:** 2027-12-31
- **Target enrollment:** 1000 (ESTIMATED)
- **Last updated:** 2026-04-21


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06862206

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06862206, "This is a Non-interventional, Study to Assess Demographic Characteristics and Patient Reported Outcomes in China Patients With SEA Treated With Benralizumab". Retrieved via AI Analytics 2026-06-29 from https://api.ai-analytics.org/clinical/NCT06862206. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*